Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Oncology Reports|February 19, 1999
Delayed diagnosis and tumor stage in Ewing's sarcomaG Bacci, M Di Fiore, S Rimondini, et al.Oncology Reports|June 22, 1999
Prognostic significance of serum LDH in Ewing's sarcoma of boneG Bacci, S Ferrari, A Longhi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2000
Neoadjuvant chemotherapy for peripheral malignant neuroectodermal tumor of bone: recent experience at the istituto rizzoliG Bacci, S Ferrari, F Bertoni, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico RizzoliG Bacci, S Ferrari, F Bertoni, et al.Acta Oncologica (Stockholm, Sweden)|February 7, 2001
Neoadjuvant chemotherapy for Ewing's sarcoma of bone in patients older than thirty-nine yearsG Bacci, S Ferrari, A Comandone, et al.Oncology Reports|February 15, 2000
Neoadjuvant chemotherapy for osteosarcoma of the extremities with synchronous lung metastases: treatment with cisplatin, adriamycin and high dose of methotrexate and ifosfamideG Bacci, A Briccoli, S Ferrari, et al.Journal of Chemotherapy (Florence, Italy)|January 6, 1999
Ifosfamide and actinomycin-D, added in the induction phase to vincristine, cyclophosphamide and doxorubicin, improve histologic response and prognosis in patients with non metastatic Ewing's sarcoma of the extremityS Ferrari, M Mercuri, P Rosito, et al.British Journal of Cancer|August 12, 2004
Phase II trial of carboplatin and etoposide for patients with recurrent high-grade gliomaE Franceschi, G Cavallo, L Scopece, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 10, 2001
A comparison of methods of loco-regional chemotherapy combined with systemic chemotherapy as neo-adjuvant treatment of osteosarcoma of the extremityG Bacci, S Ferrari, A Tienghi, et al.Tumori|April 25, 2000
Nonmetastatic osteosarcoma of the extremity: results of a neoadjuvant chemotherapy protocol (IOR/OS-3) with high-dose methotrexate, intraarterial or intravenous cisplatin, doxorubicin, and salvage chemotherapy based on histologic tumor responseS Ferrari, M Mercuri, P Picci, et al.Pageof 1